Host-mediated resolution of inflammation in periodontal diseases.
Kantarci
Alpdogan
A
Department of Peridontics and Oral Biology, Boston University, Massachusetts, USA.
Hasturk
Hatice
H
Van Dyke
Thomas E
TE
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D016207:Cytokines / Q000037:antagonists & inhibitors; D004164:Diphosphonates / Q000627:therapeutic use; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors; D044045:Lipoxins / Q000627:therapeutic use; D010510:Periodontal Diseases / Q000276:immunology*; D010518:Periodontitis / Q000276:immunology; D011480:Protease Inhibitors / Q000627:therapeutic use; D019714:Tissue Inhibitor of Metalloproteinases / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D050071:Bone Density Conservation Agents; D016207:Cytokines; D004164:Diphosphonates; D007166:Immunosuppressive Agents; D018836:Inflammation Mediators; D044045:Lipoxins; D011480:Protease Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D015118:Eicosapentaenoic Acid